News

Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and manage conditions such as Type 2 diabetes. However, doctors say there’s a ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists.
The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...
GLP-1 weight loss drugs have stood at the forefront of industry conversations recently, with concern that the reduced food intake these medications cause may lead to declining sales across the ...
GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all.
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...
Weight loss drugs like Ozempic and Mounjaro may help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to research presented at the Endocrine Society’s annual meeting ...
Natalie Muth, MD, MPH, RDN, is an adjunct associate professor at UCLA Fielding School of Public Health; co-founder of Namio Health, a virtual intensive behavioral intervention for the treatment of ...
Weather worries in the ArkLaTex should stay rather low in the next ten days. A possible tropical depression moving west ...
An Ozempic user has revealed what they believe is a 'terrifying' side effect of upping their Ozempic dose. Falling into the category of GLP-1 medications, Ozempic is FDA-approved for type two diabetes ...